The full article is currently under embargo for 12 months and will be made available on our website and PMC after this period. If you would like to access the article before it becomes publicly available, you can purchase it for personal use directly on our website. Alternatively, you may join SPUMS or EUBS to gain access to the entire issue.
Hyperbaric oxygen treatment of neonates: a case series
Gizem Kavram1, Beril Yasa1, Meltem Bor1, Leyla Bilgin1, Elmas Zeynep Ince1, Bengusu Mirasoglu2, Emine Asuman Coban1
1 Department of Pediatrics, Division of Neonatology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkiye
2 Department of Underwater and Hyperbaric Medicine, Istanbul University Istanbul Medical Faculty, Istanbul, Turkiye
Corresponding author: Dr Gizem Kavram, Department of Pediatrics, Division of Neonatology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkiye
ORCiD: 0000-0002-2014-3223
Keywords
Case reports; Hyperbaric medicine; Newborn; Thrombosis; Wound healing
Abstract
(Kavram G, Yasa B, Bor M, Bilgin L , Ince EZ, Mirasoglu B, Coban EA. Hyperbaric oxygen treatment of neonates: a case series. Diving and Hyperbaric Medicine. 2025 30 September;55(3):284−288. doi: 10.28920/dhm55.3.284-288. PMID: 40986926.)
Hyperbaric oxygen therapy (HBOT) administers oxygen under high pressure, mainly for decompression illness, carbon monoxide intoxication, wound healing, infections, and acute peripheral arterial ischaemia. There has been limited use in newborn infants. This case series aims to highlight the potential role of HBOT in management of rare and challenging conditions encountered in the neonatal period. Although HBOT is widely available, its application in newborns remains limited and not well established. We present three neonatal cases: acute peripheral ischaemia; vascular compromise due to thrombosis and compartment syndrome; and a non-healing surgical wound following omphalocele repair. We aim to emphasise the potential clinical benefit and discuss the safety profile of HBOT in select life or limb threatening neonatal pathologies. These cases demonstrate that HBOT, when use as an adjunctive therapy, may contribute to tissue salvage and overall improved outcomes in critically ill neonates. Our intention is to raise awareness and contribute to the limited literature regarding neonatal HBOT, particularly in contexts where usual treatment options are insufficient.
Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.